ADAMS JULIAN has filed 3 insider transactions across 1 company since December 2023.
Most recent transaction: a grant/award of 7900 shares of Elicio Therapeutics, Inc. ($ELTX) on May 19, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 19, 2025 | Elicio Therapeutics, Inc. | $ELTX | ADAMS JULIAN | Director | A | Stock Option (Right to Buy) | 7900 | $0.00 | 7,900.0000 | 15,953,524 | 9999.99% | 0.05% |
| Nov. 21, 2024 | Elicio Therapeutics, Inc. | $ELTX | ADAMS JULIAN | Director | A | Stock Option (Right to Buy) | 4100 | $0.00 | 4,100.0000 | 0 | 9999.99% | 0.00% |
| Dec. 28, 2023 | Elicio Therapeutics, Inc. | $ELTX | ADAMS JULIAN | Not found | A | Stock Option (right to buy) | 4100 | $0.00 | 4,100.0000 | 0 | 9999.99% | 0.00% |